Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Testes: GLP-1 reduces inflammation, indicating possible fertility benefits
Tirzepatide is a dual-action agonist that activates both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor
Gastrointestinal side effects are most common during the dose-escalation phase, when youre first starting tirzepatide or gradually increasing your dose
You can also do a hybrid approachsome appointments virtual, some in-person
Ambetter does not cover Ozempic for: Weight loss in patients without diabetes Obesity management Prediabetes (A1C 5.7% to 6.4%) Cardiovascular risk reduction in non-diabetic patients Off-label metabolic syndrome treatment This is consistent across all 27 states where Ambetter operates marketplace plans
W.HutchingsD
